Active management of the third stage of labor with sublingual misoprostol: a double-masked placebo randomized controlled trial
DOI:
https://doi.org/10.18597/rcog.615Keywords:
misoprostol, third stage of labor, uterine bleedingAbstract
Objective
To know the effectiveness and the security of the sublingual misoprostol in third stage of labor.Materials and methods
In a double-masked placebo randomized controlled trial, during vaginal delivery women were randomly assigned to receive a dose of 100 µg sublingual misoprostol or placebo in third stage of labor, immediately after cord clamping. Blood loss were measured, duration of the third stage of labor, and side effects.
Results
Blood loss in the misoprostol group was minor 599 + 426,9 mL vs. 670,3 + 482,5 mL (p>0,05) in the placebo group. Without statistically difference between groups. Duration of the third stage of labor was minor in misoprostol group 431 + 231,1 seg vs. 517,6 + 412,7 seg (p > 0,05) in the placebo group, without statistically difference. No predominance of side effects.
Conclusion
Use of 100 µg of sublingual misoprostol in the third stage of labor was well tolerated and associated with a statistically no significant trend toward less blood loss and less duration of the third stage of labor.
Author Biographies
William Angarita Peñaranda
Benjamín Rodríguez Yances
Orlando Borre Arrieta
References
Kwast BE. Postpartum haemorrhage: Its contribution to maternal mortality. Midwifery 1991;7:64-70.
Berg CJ, Atrash HK, Konin LM, Tucker M. Pregnancy related mortality in the United States, 1987-1990. Obstet Gynecol 1996;88:161-7.
Prendiville WJ, Elboume DR. Active versus expectant management of the third stage of Labour. En: Nelson JP, Crouther CA, Hodnett E, Hofmeyr GJ, Keirse MJ, eds. Pregnancy and child birth molecule of the Cochrane database of Systematic reviews. The Cochrane Colaboration: Issue I. Oxford: Update software; 1997.
Walley RL, Wilson JB, Crane JM, Mathews K, Sawyer E, Hutchens D. A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage of labour. BJOG 2000;107:1111-5.
Surbek DV, Fehr PM, Hosli I, Horegreve WH. Oral Misoprostol for Third Stage of Labor. A Randomized Placebo-Controlled Trial. Obstet Gynecol 1999;94:255-7.
Bamigboye AA, Hofmyr J, Merrell DA. Rectal misoprostol in the prevention of postpartum hemorrhage: a placebo controlled trial. Am J Obstet Gynecol 1998;179:1043-6.
Gómez I, Pinzón W, Rueda R, Sarmiento A. Uso del misoprostol intrarectal en el tratamiento de la atonía uterina. Rev Colomb Obstet Ginecol 1999;50:253-4.
Alva J, Alva H, Canales J. Eficacia del misoprostol vía sublingual comparado con vía oral en el tercer período del parto. Rev Ginecol Obst Peruana 2000;Vol XLVI No. 1.
Angarita W, Rodríguez B, Borré O. Prevención de la hemorragia postcesárea con misoprostol sublingual vs. oxitocina. Estudio presentado en el XXII Congreso Colombiano de Ginecología y Obstetricia. Cartagena 2000. Publicado en Libro Premio AFIDRO a la investigación médica 2000. Cnt Obst Ginecol;2000;6:57-61.
Hofmeyer GJ, Nikoden VC, de Jager M, Gelban BR. A randomized placebo controlled trial of oral misoprostol in the third stage of labour. Br J Obstet Gynecol 1998;105:971-5.
El-Refaey H, Nooh R, O'Brien P, Abadía M, Geary M, Valde J, Rodeck C. The Misoprostol Third stage of labour study. A randomized controlled comparison between orally administered Misoprostol and standard management. BJOG 2000;107:1104-10.
Cook CM, Sporiet EB, Murray H. A randomized clinical trial comparing oral Misoprostol with syntetic oxitocin or syntometrine in the third stage of labour. Aust N Z J Obstet Gynecol 1999;39:414-9.
Amant F, Spitz B, Timmerman D, Corremans A, Van Asshe FA. Misoprostol compared with methylergometrine for the prevention of postpartum haemorrhage: A double blind randomized trial. Br J Obstet Gynecol 1999;106:1066-70.
Borré O, Rodríguez B, Mendivil C, Angarita W, Borré J. Inducción del trabajo de parto con misoprostol vs. oxitocina. Rev Colomb Obstet Ginecol 2000;51:8-11.
Angarita W, Borré O, Rodríguez B. Manejo activo del alumbramiento con misoprostol sublingual: Un estudio clínico controlado en el Hospital de Maternidad Rafael Calvo. Congreso Nacional de Perinatología. Medellín 2001. Rev Colomb Obstet Ginecol 2002;53:87-91.
How to Cite
Downloads
Downloads
Published
Issue
Section
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
